GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 228 filers reported holding GENMAB A/S in Q1 2024. The put-call ratio across all filers is 1.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $717,110 | -20.7% | 28,536 | -5.6% | 0.02% | -19.2% |
Q1 2024 | $904,329 | +26.7% | 30,235 | +34.9% | 0.03% | +13.0% |
Q4 2023 | $713,630 | -15.6% | 22,413 | -6.5% | 0.02% | -23.3% |
Q3 2023 | $845,563 | -9.0% | 23,974 | -1.9% | 0.03% | +3.4% |
Q2 2023 | $929,308 | -1.5% | 24,449 | -2.1% | 0.03% | -6.5% |
Q1 2023 | $943,473 | +0.5% | 24,986 | +12.8% | 0.03% | -8.8% |
Q4 2022 | $939,098 | – | 22,159 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 214,848 | $6,980,000 | 2.38% |
Cutter & CO Brokerage, Inc. | 119,956 | $3,897,000 | 1.33% |
Hardman Johnston Global Advisors LLC | 933,449 | $30,328,000 | 1.29% |
Connective Portfolio Management, LLC | 18,000 | $585,000 | 1.00% |
Capricorn Fund Managers Ltd | 148,411 | $4,822,000 | 0.88% |
TORRAY INVESTMENT PARTNERS LLC | 131,708 | $4,279,000 | 0.82% |
First Light Asset Management, LLC | 160,885 | $5,227,000 | 0.61% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,857 | $57,189,000 | 0.60% |
Yorktown Management & Research Co Inc | 10,100 | $328,000 | 0.42% |
Integrated Investment Consultants, LLC | 18,550 | $602,000 | 0.22% |